Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
1. Kumar VR, Abbas AK, Aster JC, Debnath J, Das A (eds). Robbins, Cotran, and Kumar Pathologic Basis of Disease (Robbins Pathology). 11th ed. Philadelphia, PA: Elsevier; 2025.
2. Abbas AK, Lichtman AH, Pillai S. Basic Immunology: Functions and Disorders of the Immune System. 7th ed. Philadelphia, PA: Elsevier; 2023.
3. Hall JE, Hall ME. Guyton and Hall Textbook of Medical Physiology. 14th ed. Philadelphia, PA: Elsevier; 2021.
4. Norris TL. Porth's Pathophysiology: Concepts of Altered Health States. 10th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2019.
5. Bruyere HJ. 100 Case Studies in Pathophysiology. 1st ed. Baltimore, MD: Lippincott Williams & Wilkins; 2009.
6. McCance KL, Huether SE. Pathophysiology: The Biologic Basis for Disease in Adults and Children. 9th ed. St. Louis, MO: Elsevier; 2022.
7. Dembic Z. The Cytokines of the Immune System: The Role of Cytokines in Disease Related to Immune Response. San Diego, CA: Academic Press; 2015.
8. Danieli MG, Casciaro M, Paladini A, et al. Exposome: epigenetics and autoimmune diseases. Autoimmune Rev. 2024;23(6):103584.
9. Mitchell RN, Kumar V, Fausto N, Abbas AK, Aster JC. Pocket Companion to Robbins & Cotran Pathologic Basis of Disease. 13th ed. Philadelphia, PA: Elsevier; 2025.
10. Rogers JL. McCance and Huether's Pathophysiology: The Biological Basis for Diseases in Adults and Children. 9th ed. St. Louis, MO: Elsevier; 2022.
11. Gershwin ME, Tsokos GC, Diamond B (eds). The Rose and Mackay Textbook of Autoimmune Diseases. 7th ed. San Diego, CA: Academic Press; 2024.
13. Mahmoudi M. Challenging Cases in Rheumatology and Diseases of the Immune System. New York, NY: Springer; 2013.
14. Fernandez J, Mandell BF. Merck Manual Professional Version. Overview of Allergic and Atopic Disorders. Available at https://www.merckmanuals.com/professional/immunology-allergic-disorders/allergic-autoimmune-and-other-hypersensitivity-disorders/overview-of-allergic-and-atopic-disorders. Last accessed October 1, 2025.
15. Kayiran MA, Akdeniz N. Diagnosis and treatment of urticaria in primary care. North Clin Istanb. 2019;6(1):93–99.
16. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Working Group Report: 2020 Focused Updates to the Asthma Management Guidelines. Available at https://www.nhlbi.nih.gov/resources/2020-focused-updates-asthma-management-guidelines. Last accessed October 1, 2025.
17. Makic MF, Martinez-Kratz MR (eds). Ackley and Ladwig's Nursing Diagnosis Handbook: An Evidence-Based Guide to Planning Care. 13th ed. St. Louis, MO: Elsevier; 2023.
18. AAAAI/ACAAI JTF Atopic Dermatitis Guideline Panel, Chu DK, Schneider L, et al. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE– and Institute of Medicine–based recommendations. Ann Allergy Asthma Immunol. 2024;132(3):274–312.
19. LexiDrug. Available at https://online.lexi.com. Last accessed October 1, 2025.
20. Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report. Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol. 2006;117(2):391–397.
21. Cardona V, Asotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidelines: summary. J Allergy Clin Immunol. 2020;13(10):100472.
22. Golden DBK, Wang J, Waserman, S, et al. Anaphylaxis: a 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024;132(2):124–176.
23. Gulanick M, Myers JL. Nursing Care Plans: Diagnoses, Interventions, and Outcomes. 11th ed. St. Louis, MO: Elsevier; 2026.
24. Parikh P. Anaphylaxis. Available at https://allergyasthmanetwork.org/anaphylaxis. Last accessed October 1, 2025.
25. Prince BT, Mikhail I, Stukus DR. Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities. J Asthma Allergy. 2018;11:143–151.
26. Gupta RS, Warren CM, Smith BM, et al. The public health impact of parent-reported childhood food allergies in the United States. Pediatrics. 2018;142(6):e20181235.
27. Zablotsky B, Black LI, Akinbami LJ. Diagnosed allergic conditions in children 0–17 years: United States, 2021. NCHS Data Brief. 2023;459:1–8.
28. Gupta RS, Warren CM, Smith BM, et al. Prevalence and severity of food allergies among U.S. adults. JAMA Netw Open. 2019;2(1):e185630.
29. Ng AE, Boersma P. Diagnosed allergic conditions in adults: United States, 2021. NCHS Data Brief. 2023;460:1–8.
30. Food Allergy Research and Education. Facts and Statistics. Available at https://www.foodallergy.org/resources/facts-and-statistics. Last accessed April 1, 2025.
31. Gupta R, Holdford D, Bilaver L, et al. The economic impact of childhood food allergy in the United States. JAMA Pediatr. 2013;167(11):1026–1031.
32. Boyce JA, Assa'ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126(6 Suppl):S1–S58.
33. Burks AW, Tang M, Sicherer S, et al. ICON: food allergy. J Allergy Clin Immunol. 2012;129(4):906–920.
34. Liu AH, Jaramillo R, Sicherer SH, et al. National prevalence and risk factors for food allergy and relationship to asthma: results from the National Health and Nutrition Examination Survey 2005–2006. J Allergy Clin Immunol. 2010;126(4):798–806.
35. Sicherer SH, Wood RA, American Academy of Pediatrics Section on Allergy and Immunology. Allergy testing in childhood: using allergen-specific IgE tests. Pediatrics. 2012;129(1):193–197.
36. Food Allergy Research and Education. Facts and Statistics. Available at https://www.foodallergy.org/life-with-food-allergies/food-allergy-101/facts-and-statistics. Last accessed October 1, 2025.
37. United States Department of Agriculture. Food Allergies: The "Big 9." Available at https://www.fsis.usda.gov/food-safety/safe-food-handling-and-preparation/food-safety-basics/food-allergies-big-9. Last accessed October 1, 2025.
38. Bischoff S, Crowe SE. Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology. 2005;128(4):1089–1113.
39. Parrish CP. A review of food allergy panels and their consequences. Ann Allergy Asthma Immunol. 2023;131(4):421–426.
40. Sur LM, Armat I, Duca E, et al. Food allergy a constant concern to the medical world and healthcare providers: practical aspects.Life (Basel). 2021;11(11):1204.
41. Togias A, Cooper SF, Acebal ML, et al. Addendum guidelines for the prevention of peanut allergy in the United States: report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel. J Allergy Clin Immunol. 2017;139(1):29–44.
42. Sicherer SH, Sampson HA. Food allergy: a review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J Allergy Clin Immunol. 2018;141(1):41–58.
43. Gupta RS, Warren CM, Smith BM, et al. Prevalence and severity of food allergies among U.S. adults. JAMA Netw Open. 2019;2(1):e185630.
44. Sansweet S, Rolling C, Ebisawa M. Reaching communities through food allergy advocacy, research, and education: a comprehensive analysis. J Allergy Clin Immunol. 2024;12(2):310–315.
45. Food Allergy Research and Education. Food Allergy Essentials: Common Allergens. Available at https://www.foodallergy.org/living-food-allergies/food-allergy-essentials/common-allergens. Last accessed October 1, 2025.
46. Centers for Disease Control and Prevention. FastStats: Asthma. Available at https://www.cdc.gov/nchs/fastats/asthma.htm. Last accessed October 1, 2025.
47. Ortega VE, Izuierdo M, Albert RK. Merck Manual Professional Version. Asthma. Available at https://www.merckmanuals.com/professional/pulmonary-disorders/asthma-and-related-disorders/asthma. Last accessed October 1, 2025.
48. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention: 2024 Update. Available at https://ginasthma.org/wp-content/uploads/2024/05/GINA-2024-Strategy-Report-24_05_22_WMS.pdf. Last accessed October 1, 2025.
49. American College of Rheumatology. Diseases and Conditions. Available at https://rheumatology.org/patients/diseases-and-conditions. Last accessed October 1, 2025.
51. Foster AL, Boring MA, Lites TD, et al. Distribution of arthritis subtypes among adults with arthritis in the United States, 2017– March 2020. Prev Chronic Dis. 2025;22:240393.
52. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Rheumatoid Arthritis. Available at https://www.niams.nih.gov/health-topics/rheumatoid-arthritis. Last accessed October 1, 2025.
53. Johns Hopkins Arthritis Center. RA Pathophysiology. Available at https://www.hopkinsarthritis.org/arthritis-info/rheumatoid-arthritis/ra-pathophysiology-2. Last accessed October 1, 2025.
54. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580–1588.
55. Firestein GS. Etiology, pathogenesis, and clinical manifestations of rheumatoid arthritis. In: Firestein GS, Budd RC, Gabriel SE, et al. (eds). Kelley and Firestein's Textbook of Rheumatology. 11th ed. Philadelphia, PA: Elsevier; 2021:1181–1257.
56. Smolen JS, Landewé R, Bijlsma J, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3–18.
57. Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthrit Care Res. 2021;73(7):924–939.
58. Allameen NA, Lai YWL, Lian G, et al. Physiotherapy and occupational therapy in rheumatoid arthritis: bridging functional and comorbidity gaps. Best Pract Res Clin Rheumatol. 2025;39(1):102032.
59. Falvo D, Holland BE. Medical and Psychosocial Aspects of Chronic Illness and Disability. 6th ed. Burlington, MA: Jones & Bartlett Learning; 2017.
60. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases. Lupus: A Patient Care Guide for Nurses and Other Health Professionals. Bethesda, MD: The Institute; 2006.
61. Wallace DJ. The Lupus Book: A Guide for Patients and Their Families. 7th ed. New York, NY: Oxford; 2024.
62. Yaseen K, Merola JF. Merck Manual Professional Version. Systemic Lupus Erythematosus (SLE). Available at https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/systemic-rheumatic-diseases/systemic-lupus-erythematosus-sle. Last accessed October 1, 2025.
63. Lupus Foundation of America. Lab Tests for Lupus. Available at https://www.lupus.org/resources/lab-tests-for-lupus. Last accessed October 1, 2025.
64. U.S. Food and Drug Administration. FDA News Release: FDA Approves Benlysta to Treat Lupus. Available at https://wayback.archive-it.org/7993/20170112024037/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm246489.htm. Last accessed October 1, 2025.
65. Collins CE, Dall'Era M, Kan H, et al. Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the Observe study in the USA. Lupus Sci Med. 2016;3(1):e000118.
66. Touma Z, Sayani A, Pineau CA, et al. Belimumab use, clinical outcomes and glucocorticoid reduction in patients with systemic lupus erythematosus receiving belimumab in clinical practice settings: results from the OBSErve Canada Study. Rheumatol Int. 2017;37(6):865–873.
67. American College of Rheumatology. A New Era for the Treatment of Lupus. Available at https://rheumatology.org/patient-blog/a-new-era-for-the-treatment-of-lupus. Last accessed October 1, 2025.
68. Lupus Foundation of America. Lupus Foundation of America celebrates FDA approval of Saphnelo (anifrolumab-fnia) as a new treatment for lupus. Available at https://www.lupus.org/news/fda-approval-of-saphnelo-anifrolumabfnia-new-treatment-lupus. Last accessed October 1, 2025.
69. Yaseen K, Merola JF. Merck Manual Professional Version. Sjögren Syndrome. Available at https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/systemic-rheumatic-diseases/sj%C3%B6gren-syndrome?query=sjogren%20syndrome. Last accessed October 1, 2025.
71. Ramos-Casals M, Tzioufas AG, Stone JH, Sisó A, Bosch X. Treatment of primary Sjögren syndrome: a systematic review. JAMA. 2010;304(4):452–460.
72. American Academy of Ophthalmology. Dry Eye Syndrome PPP-2018. Available at https://www.aao.org/preferred-practice-pattern/dry-eye-syndrome-ppp-2018. Last accessed October 1, 2025.
73. Kruszka P, O'Brian RJ. Diagnosis and management of Sjögren syndrome. Am Fam Physician. 2009;79(6):465–470.
74. Yaseen K, Merola JF. Merck Manual Professional Version. Systemic Sclerosis. Available at https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/systemic-rheumatic-diseases/systemic-sclerosis. Last accessed October 1, 2025.
75. World Health Organization. HIV/AIDS: Key Facts. Available at https://www.who.int/news-room/fact-sheets/detail/hiv-aids. Last accessed October 1, 2025.
76. Centers for Disease Control and Prevention. Fast Facts: HIV in the United States. Available at https://www.cdc.gov/hiv/data-research/facts-stats/index.html. Last accessed October 1, 2025.
77. Cachay ER, Muzny CA. Merck Manual Professional Version. Human Immunodeficiency Virus (HIV) Infection. Available at https://www.merckmanuals.com/professional/infectious-diseases/human-immunodeficiency-virus-hiv/human-immunodeficiency-virus-hiv-infection. Last accessed October 1, 2025
78. Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011;1(1):a006841.
79. Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Available at https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv. Last accessed October 1, 2025.
80. Centers for Disease Control and Prevention. Trends in HIV-2 diagnoses and use of the HIV-1/HIV-2 differentiation test—United States, 2010–2017. MMWR. 2020;69(3);63–66.
81. Centers for Disease Control and Prevention. Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings. Available at https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5514a1.htm. Last accessed October 1, 2025.
82. Centers for Disease Control and Prevention. Recommendations for HIV Prevention with Adults and Adolescents with HIV in the United States, 2014: Summary for Clinical Providers. Available at https://stacks.cdc.gov/view/cdc/44065. Last accessed October 1, 2025.
83. Simon V, Ho DD, Karim QA. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet. 2006;368(9534):489–504.
84. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med. 1998;339(1):33–39.
85. U.S. Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Available at https://clinicalinfo.hiv.gov/sites/default/files/guidelines/archive/AdultandAdolescentGL_2021_08_16.pdf. Last accessed October 18, 2022.
86. Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Department of Health and Human Services. Available at https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv. Last accessed October 1, 2025.
87. Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission. Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. Department of Health and Human Services. Available at https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections. Last accessed October 1, 2025.
88. International Association of Providers of AIDS Care. Viral Load. Available at https://www.iapac.org/fact-sheet/viral-load. Last accessed October 1, 2025.
89. INSIGHT START Study Group, Lundgren JD, Babiker AG, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807.
90. TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373(9):808–822.
91. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the Prevention and treatment of Opportunistic Infections in Adults and Adolescents with HIV. National Institutes of Health, HIV Medicine Association, and Infectious Diseases Society of America. Available at https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections. Last accessed October 1, 2025.
92. Gulanick M, Myers JL. Nursing Care Plans: Diagnoses, Interventions, and Outcomes. 10th ed. St. Louis, MO: Elsevier; 2022.
93. Ladwig GB, Ackley BJ, Flynn Makic MB. Mosby's Guide to Nursing Diagnosis. 6th ed. St. Louis, MO: Elsevier; 2019.
94. Gubrud P, Carno M, Bauldoff G. LeMone and Burke's Medical-Surgical Nursing: Clinical Reasoning in Patient Care. 7th ed. Pearson Australia; 2019.
95. National Institute of Allergy and Infectious Diseases. Disorders of the Immune System. Available at https://www.niaid.nih.gov/research/immune-system-disorders. Last accessed October 1, 2025.
96. American Academy of Allergy, Asthma, and Immunology. Primary Immunodeficiency Disease. Available at https://www.aaaai.org/conditions-and-treatments/primary-immunodeficiency-disease. Last accessed October 1, 2025.
97. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. Chest. 1992;101:1644–1655.
98. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med. 2003;29:530–538.
99. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063–e1143.
100. Surviving Sepsis Campaign: Guidelines and Bundles. Available at https://www.sccm.org/SurvivingSepsisCampaign/Guidelines. Last accessed October 1, 2025
101. Singh JA, Guyatt G, Ogdie A, et al. Special article: 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. Arthritis Rheumatol. 2019;71(1):532.
102. Yaseen K, Mandell BF. Merck Manual Professional Version. Ankylosing Spondylitis. Available at https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/joint-disorders/ankylosing-spondylitis. Last accessed October 1, 2025.
103. Ward MM, Deodhar A, Akl EA, et al. 2018 update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheumatol. 2020;71(10):1285-1299.
104. American College of Rheumatology. Reactive Arthritis. Available at https://rheumatology.org/patients/reactive-arthritis. Last accessed October 1, 2025.
105. Yaseen K, Merola JF. Merck Manual Professional Version. Idiopathic Inflammatory Myopathies. Available at https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/systemic-rheumatic-diseases/idiopathic-inflammatory-myopathies. Last accessed October 1, 2025.
106. Villa-Forte A, Mandell BF. Merck Manual Professional Version. Overview of Vasculitis. Available at https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/vasculitis/overview-of-vasculitis. Last accessed October 1, 2025.
107. Villa-Forte A, Mandell BF. Merck Manual Professional Version. Polymyalgia Rheumatica. Available at https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/vasculitis/polymyalgia-rheumatica. Last accessed October 1, 2025.
108. Villa-Forte A, Mandell BF. Merck Manual Professional Version. Giant Cell Arteritis. Available at https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/vasculitis/giant-cell-arteritis. Last accessed October 1, 2025.
109. Centers for Disease Control and Prevention. Lyme Disease: Data and Surveillance. Available at https://www.cdc.gov/lyme/data-research/facts-stats/surveillance-data-1.html . Last accessed October 1, 2025.
110. Centers of Disease Control and Prevention. New Lyme-Disease-Bacteria Species Discovered. Available at https://archive.cdc.gov/#/details?url=https://www.cdc.gov/media/releases/2016/p0208-lyme-disease.html. Last accessed October 1, 2025.
111. Bush LM, Vasquez-Pertejo MT, Muzny CA. Merck Manual Professional Version. Lyme Disease. Available at https://www.merckmanuals.com/professional/infectious-diseases/spirochetes/lyme-disease. Last accessed October 1, 2025.
112. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. AAN/ACR/IDSA 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease. Clin Infect Dis. 2021 ;72(1):e1e48.
113. Genetic and Rare Diseases Information Center. Behçet Disease. Available at https://rarediseases.info.nih.gov/diseases/848/behcet-disease. Last accessed October 18, 2025.
114. Genetic and Rare Diseases Information Center. Acute Febrile Mucocutaneous Lymph Node Syndrome. Available at https://rarediseases.info.nih.gov/diseases/6816/kawasaki-disease. Last accessed October 18, 2025.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.